Newsletter Says Sell China Sky One Medical (CSKI)
Tweet
Share
E-mail
The Asia Edge newsletter is now recommending investors Sell China Sky One Medical (NASDAQ: CSKI), after first recommending investors to Buy the stock in mid-August.
The newsletter writer Robert Hsu said after meetings with the founder and CEO Yan-Qing Liu, they strongly believe the company needs to improve its internal control and corporate governance. The newsletter notes CKSI once hired a 26-year-old graduate student as a director on its board. It was only after investors found out about this that the company replaced him with a former management consultant from McKinsey & Co.. Hsu says,"this kind of poor internal control and lack of governance is not uncommon among Chinese mom and pop firms, but it's unacceptable for a company publicly listed on a U.S. exchange."
The newsletter writer Robert Hsu said after meetings with the founder and CEO Yan-Qing Liu, they strongly believe the company needs to improve its internal control and corporate governance. The newsletter notes CKSI once hired a 26-year-old graduate student as a director on its board. It was only after investors found out about this that the company replaced him with a former management consultant from McKinsey & Co.. Hsu says,
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- Scorpion Capital says short Twist Biosciences
- Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
Create E-mail Alert Related Categories
Insiders' Blog, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
